Cim Investment Management Inc. Sells 9,943 Shares of Lam Research Corporation $LRCX

Cim Investment Management Inc. lessened its holdings in Lam Research Corporation (NASDAQ:LRCX) by 50.6% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,715 shares of the semiconductor company’s stock after selling 9,943 shares during the period. Cim Investment Management Inc.’s holdings in Lam Research were worth $1,301,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Howard Hughes Medical Institute bought a new position in shares of Lam Research during the 2nd quarter worth approximately $27,000. Triumph Capital Management acquired a new stake in Lam Research in the 3rd quarter valued at $27,000. Strategic Wealth Investment Group LLC bought a new stake in Lam Research in the second quarter valued at $29,000. Delos Wealth Advisors LLC bought a new stake in Lam Research in the second quarter valued at $30,000. Finally, Country Trust Bank acquired a new position in Lam Research during the second quarter worth $39,000. Institutional investors own 84.61% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Douglas R. Bettinger sold 50,057 shares of the business’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total value of $11,214,269.71. Following the completion of the transaction, the chief financial officer owned 1,081,705 shares of the company’s stock, valued at $242,334,371.15. The trade was a 4.42% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Eric Brandt sold 35,000 shares of the firm’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the sale, the director directly owned 253,705 shares in the company, valued at $57,235,848. The trade was a 12.12% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 130,886 shares of company stock worth $29,658,802. Company insiders own 0.31% of the company’s stock.

Key Stories Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Industry tailwinds from AI and memory are being highlighted as a near-term bottleneck that benefits wafer‑fabrication equipment suppliers like Lam, supporting stronger order outlooks for 2026. AI’s Next Bottleneck Is Driving These Stocks Higher
• Positive Sentiment: Brokerage consensus remains constructive: LRCX has a “Moderate Buy” consensus from brokerages, reinforcing buy-side confidence and underpinning demand for the shares. Lam Research Corporation (NASDAQ:LRCX) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
• Positive Sentiment: Analysts and market writeups point to rising DRAM memory spending trends as supportive for Lam’s equipment sales; Morgan Stanley recently nudged its price target higher to $254 (from $244), citing upside from memory/AI capex even while keeping an Equal Weight rating. What Does DRAM Memory Spending Trend Mean for Lam Research (LRCX)
• Positive Sentiment: Investor letters and fund commentary (e.g., Artisan Partners) note a strong demand uptick for Lam, underscoring institutional recognition of improved end‑market dynamics tied to AI and memory. Lam Research (LCRX) Gained From Strong Demand Uptick
• Neutral Sentiment: Market commentary and investor pieces reiterate a bullish thesis on LRCX based on secular AI/memory tailwinds and Lam’s strong margins and prior earnings beat, but note relatively elevated valuation metrics (forward P/E) that could temper near-term upside. Is Lam Research Corporation (LRCX) A Good Stock To Buy Now?

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Susquehanna set a $325.00 target price on shares of Lam Research and gave the company a “positive” rating in a research note on Thursday, January 29th. TD Cowen increased their target price on shares of Lam Research from $170.00 to $290.00 and gave the stock a “buy” rating in a research report on Thursday, January 29th. UBS Group set a $300.00 price target on shares of Lam Research in a report on Thursday, January 29th. Barclays boosted their price target on shares of Lam Research from $250.00 to $255.00 and gave the company an “equal weight” rating in a research report on Tuesday, March 10th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $200.00 price objective (up from $175.00) on shares of Lam Research in a research note on Monday, December 15th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Lam Research presently has a consensus rating of “Moderate Buy” and an average price target of $245.35.

Lam Research Trading Up 3.2%

NASDAQ:LRCX opened at $226.47 on Wednesday. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $256.68. The firm has a market capitalization of $282.81 billion, a price-to-earnings ratio of 46.41, a PEG ratio of 2.36 and a beta of 1.77. The business’s 50-day moving average price is $225.63 and its two-hundred day moving average price is $175.37.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.10. The company had revenue of $5.34 billion during the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The company’s revenue for the quarter was up 22.1% compared to the same quarter last year. During the same period in the previous year, the company earned $0.91 EPS. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, equities analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be paid a $0.26 dividend. This represents a $1.04 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s dividend payout ratio is presently 21.31%.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.